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Abstract
Background: Knowledge of spatial patterns of dengue virus (DENV) infection is important for understanding transmission
dynamics and guiding effective disease prevention strategies. Because movement of infected humans and mosquito vectors
plays a role in the spread and persistence of virus, spatial dimensions of transmission can range from small household foci to
large community clusters. Current understanding is limited because past analyses emphasized clinically apparent illness and
did not account for the potentially large proportion of inapparent infections. In this study we analyzed both clinically
apparent and overall infections to determine the extent of clustering among human DENV infections.
Methodology/Principal Findings: We conducted spatial analyses at global and local scales, using acute case and
seroconversion data from a prospective longitudinal cohort in Iquitos, Peru, from 1999–2003. Our study began during a
period of interepidemic DENV-1 and DENV-2 transmission and transitioned to epidemic DENV-3 transmission. Infection
status was determined by seroconversion based on plaque neutralization testing of sequential blood samples taken at
approximately six-month intervals, with date of infection assigned as the middate between paired samples. Each year was
divided into three distinct seasonal periods of DENV transmission. Spatial heterogeneity was detected in baseline
seroprevalence for DENV-1 and DENV-2. Cumulative DENV-3 seroprevalence calculated by trimester from 2001–2003 was
spatially similar to preexisting DENV-1 and DENV-2 seroprevalence. Global clustering (case-control Ripley’s K statistic)
appeared at radii of ,200–800 m. Local analyses (Kuldorf spatial scan statistic) identified eight DENV-1 and 15 DENV-3
clusters from 1999–2003. The number of seroconversions per cluster ranged from 3–34 with radii from zero (a single
household) to 750 m; 65% of clusters had radii .100 m. No clustering was detected among clinically apparent infections.
Conclusions/Significance: Seroprevalence of previously circulating DENV serotypes can be a predictor of transmission risk
for a different invading serotype and, thus, identify targets for strategically placed surveillance and intervention.
Seroprevalence of a specific serotype is also important, but does not preclude other contributing factors, such as mosquito
density, in determining where transmission of that virus will occur. Regardless of the epidemiological context or virus
serotype, human movement appears to be an important factor in defining the spatial dimensions of DENV transmission and,
thus, should be considered in the design and evaluation of surveillance and intervention strategies.
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Introduction
Dengue viruses (DENVs) cause more human morbidity and
mortality worldwide than any other arthropod-borne virus [1,2].
The principal vector is Aedes aegypti, a highly anthropophilic
mosquito with relatively short dispersal tendencies that is known to
bite people primarily during daylight hours as they engage in their
daily activity patterns [3,4,5]. Interactions between relatively
mobile humans and relatively sedentary mosquitoes are processes
that underlie the dynamics of DENV transmission through space
and time. Human movement can transport virus across small
(households and neighborhoods) and large scales (village, city,
country, and international) [6,7,8]. The contribution of infected
female mosquitoes is restricted to short-range flight dispersal
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(household, neighborhood) [3,9,10,11,12,13]. At small scales,
several investigators have described dengue cases clustered within
a household or neighboring houses [14,15,16,17,18,19,20]. The
spatial dimension of DENV transmission beyond this very local
scale of a household and its neighbors has been difficult to measure
and thus a challenge to define [6,21,22]. One limitation is that
previous investigations tended to focus on individuals with
detectable dengue disease (fever and more severe illness), which
represents only a fraction of all infections because, typically, a
significant portion of human dengue infections are inapparent
[23,24,25].
Transmission patterns of DENV in a geographic area are
influenced by complex immunological interactions among the four
closely related, antigenically distinct dengue viruses (DENV-1,
DENV-2, DENV-3 and DENV-4) that make up the DENV
complex [26]. Infection with one or more serotype(s) can result in
a range of clinical outcomes, from asymptomatic infection to
classic dengue fever, to more serious dengue hemorrhagic fever
(DHF) and dengue shock syndrome (DSS). Because serotypes are
antigenically distinct, primary infection confers lifelong homolo-
gous immunity, whereas heterologous cross-protection is short-
lived [1,27,28,29]. In many parts of Southeast Asia, especially in
large urban centers, endemic transmission of all four serotypes
occurs and broad scale, super-annual oscillations in dengue
incidence have been reported [30]. In contrast, in many parts of
Central and South America, epidemic transmission over the past
three decades has occurred in distinct waves that are associated
with invasion and amplification of single DENV serotypes or
genotypes [31]. In those settings, endemic transmission patterns
can be influenced by ambient levels of serotype-specific herd
immunity and epidemic transmission can occur when a novel virus
serotype enters a region where the majority of the population is
immunologically naı¨ve [17].
Since the re-introduction of DENV-1 into Iquitos during 1990,
the city has experienced continuous DENV transmission with
major epidemics occurring in association with novel serotype
introductions. DENV-1 was introduced in 1991 and DENV-2 in
1995 [32,33,34]. By 2000, DENV-1 and DENV-2 were being
transmitted at low, consistent levels from year to year. DENV-3
was then introduced in 2001 [35] and by late 2002 had replaced
DENV-1 and DENV-2 as the dominant circulating serotype,
causing a major outbreak of febrile illness. The local Peruvian
Ministry of Health (PMoH) reacted by implementing household-
level mosquito interventions (i.e., spraying insecticide inside
houses), which appears to have truncated the epidemic [25].
To more carefully delineate patterns of transmission in Iquitos,
we examined serological data from a city-wide, long-term,
prospective, longitudinal study to describe and compare the
spatial dimensions of DENV transmission across periods that
transitioned from relatively low to high force of infection; i.e., from
interepidemic to epidemic transmission. We compared clustering
of infections (global and local) to test the hypothesis that the
invasion of a new virus serotype or genotype follows a specific
pattern: rapid, broad scale geographic spread at low levels [25],
followed by large clusters of increased force of infection in
predictable geographic regions. We also compared clustering of
acute cases, as defined by Morrison et al 2001 [25]. At distances
less than 100 m, we suspect that both mosquitoes and humans
participate in virus transmission [3,9,10,11,12,13], but beyond
100 m, it is likely primarily humans that define the spatial
dimensions of the clusters. Previous research indicates that human
movement often occurs well beyond a 100 m radius from their
home (Vazquez Prokopec, Paz Soldan, Elder, Stoddard unpub-
lished). Our results provide details on the dynamics of DENV
invasion and establishment, have implications for evaluating
intervention strategies, can be used to enhance dengue surveillance
and prevention programs, and may be applicable to an improved
understanding of transmission dynamics of other mosquito-borne
pathogens.
Methods
Human Use Statement
The study protocol was approved by the University of
California, Davis (Protocol 2220210788-4(994054), Instituto
Nacional de Salud, and Naval Medical Research Center (Protocol
#NMRCD.2001.0008 (DoD 31574) Institutional Review Boards
in compliance with all Federal regulations governing the
protection of human subjects. STROBE checklist included in
supporting information (Checklist S1).
Study area and population
Our cohort study was conducted in Iquitos, an isolated city of
,400,000 people in the northeastern Amazon Basin portion of
Peru. We divided the city into eight distinct geographical zones for
our study (described in detail in Morrison et al 2004 [36]). The
population consists of an approximate 1:1 sex ratio, and about
36% of the population ,=17 years of age (http://desa.inei.gob.
pe/).Written informed consent was obtained from participants
older than 17 years and from parents of participants younger than
18. In addition, assent was obtained from participants 8–17 years
of age. If participants were unable to read and sign the consent
form, oral consent was obtained and documented. Blood samples
were obtained from participants between January 1999 and
August 2003, as described in Morrison et al 2010 [25] (Figure 1).
Serum samples were tested for antibody to DENV serotypes based
on plaque reduction neutralization test (PRNT) as described
previously [25]. Briefly, heat-inactivated sera were incubated with
DENV (DENV-1:16007; DENV-2: 16681; DENV-3: IQT1728)
prior to inoculation onto BHK-21 cells. The level of neutralization
used for the cutoff was PRNT70, with cutoff dilutions of 1:60, 1:80
and 1:60 for DENV-1, DENV-2 and DENV-3, respectively. For
more details, see Morrison et al 2010 [25].
Author Summary
To target prevention and control strategies for dengue
fever, it is essential to understand how the virus travels
through the city. We report spatial analyses of dengue
infections from a study monitoring school children and
adult family members for dengue infection at six-month
intervals from 1999–2003, in the Amazonian city of Iquitos,
Peru. At the beginning of the study, only DENV serotypes 1
and 2 were circulating. Clusters of infections of these two
viruses were concentrated in the northern region of the
city, where mosquito indices and previous DENV infection
were both high. In 2002, DENV-3 invaded the city,
replacing DENV-1 and -2 as the dominant strain. During
the invasion process, the virus spread rapidly across the
city, at low levels. After this initial phase, clusters of
infection appeared first in the northern region of the city,
where clusters of DENV-1 and DENV-2 had occurred in
prior years. Most of the clusters we identified had radii
.100 meters, indicating that targeted or reactive treat-
ment of these high-risk areas might be an effective
proactive intervention strategy. Our results also help
explain why vector control within 100 m of a dengue case
is often not successful for large-scale disease prevention.
Spatial Dimensions of Dengue Transmission
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Extension of Morrison et al 2010
Morrison et al 2001 [25] provide a detailed description of overall
patterns of DENV transmission in Iquitos from 1999–2005. In
that study, the authors described data collected through active
school-based surveillance and a longitudinal cohort, showing
increasing seroprevalence of DENV-3 throughout the study. Here
we extend these observational results with a more detailed analysis
of spatial patterns in human infection.
Figure 1. Distribution of cohort participant houses throughout the 8 zones of Iquitos. Each circle marks the location of a participant
home.
doi:10.1371/journal.pntd.0001472.g001
Spatial Dimensions of Dengue Transmission
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Cases and controls
Infections (i.e., cases) for our analyses below were defined as
participants who showed evidence of serotype-specific serocon-
version between two paired blood samples, based on PRNT.
Controls were defined as susceptible, seronegative participants
who had no serological evidence of serotype-specific infection
between paired blood samples.
Both cases and controls were limited to participants whose
paired blood samples were less than 242 days apart, corresponding
to the 75% quartile of the distribution of intervals. Analyses of the
dataset were run independently for each distinct serotype. A
trimester-specific dataset was constructed containing all cases and
controls with middates falling within that period. Yearly trimester
intervals (Jan–Apr: end of the high transmission season, May–Aug:
low transmission season, and Sept–Dec: beginning of the high
transmission season) were chosen for analyses because they
capture intra-annual variation in the Iquitos DENV transmission
season. Although there is variation from year to year, the high
DENV transmission season in Iquitos generally occurs from Sept–
Apr, unless emergency vector control interventions decrease
transmission prior to April. In general, consistently lower rates
of transmission were observed between May and July [25,31].
Seroprevalence
At the initiation of the cohort (Jan 1999), DENV-1 and DENV-
2 were circulating at low levels throughout Iquitos. The baseline
serostatus of participants was determined over the eight geo-
graphic zones using samples collected between January and
October of 1999 [25].
To measure the prevalence of antibodies for DENV-3
throughout the course of its invasion into Iquitos, overall
participant serostatus was calculated using the most recent sample
taken from each participant, beginning in Aug 2002. As with
baseline seroprevalence rates, cumulative seroprevalence of
DENV-3 was estimated for the eight Iquitos geographical regions
from Jan 2002–May 2003.
To determine if the invasion of DENV-3 was positively
correlated with the baseline seroprevalence of DENV-1/DENV-
2 across the city prior to its introduction, we conducted a
Spearman Rank correlation test, comparing the DENV-3
seroprevalence by zone in each trimester to the baseline DENV-
1/DENV-2 seroprevalence. For this analysis, as the r coefficient
approaches 21 or 1 the two patterns are more negatively or
positively correlated, respectively.
Sampling effort across the eight geographical zones varied, due
primarily to the location of commercial versus residential areas of
the city (Figure 2). To visualize the spatial pattern of accumulating
seroprevalence throughout the study period, we used spatial
kernels based on the intensity of points in the study area for each
trimester. Points were the coordinates of participants’ homes. We
first generated a kernel for the pattern of all participants with a
middate in a given trimester. Similarly, we then generated a kernel
of individuals immune to DENV-3 (presenting with antibody in
the first blood sample). Because of the nature of kernel estimation,
estimates where there are no points nearby tend to be small.
Calculating the ratio of immune to all participants to calculate
seroprevalence would, therefore, result in artificially high estimates
when both of these values were small. For the kernel of immune
individuals, we thus set all values falling into the first quartile to
zero in order to avoid gross overestimates of seroprevalence. All
kernels were estimated assuming a standard, isotropic Gaussian
kernel with fixed bandwidth (s=175), which was determined by
visual inspection of the results. All analyses were conducted using
the SpatStat package of the R Statistical Computing Environment
[37].
Spatial analyses
To determine the spatial dynamics of DENV transmission, we
examined patterns of both global and local clustering. The global
analysis was used to examine the spatial pattern of seroconversions
within a defined reference window (the eight zones) and, by
comparison to the pattern of controls, to test the hypothesis that
seroconversions clustered in space. On the other hand, local
clustering uses a specific spatial window to look for the over-
dispersion of cases in comparison to controls within that window.
This window of delimited radius X moves across the geocoded
data for each time interval and indicates when cases appear in
greater numbers than expected.
Global pattern clustering
Global patterns of dengue seroconversions were analyzed within
each trimester using a case-control Ripley’s K statistic [38]. When
used within a Monte Carlo framework, this allows for inferences to
be made about the structure of a point pattern. To test the
hypothesis that dengue seroconversions clustered in space, we
simulated an inhomogeneous K function (because of the
heterogeneous sampling pattern) comparing random samples of
control points to cases of dengue infection in each time interval
using the participants’ home as their spatial reference. Simulations
were conducted by resampling the control points with replacement
99 times to estimate the minimum and maximum K functions for
susceptibles, generating a 99% probability envelope. The number
of control points sampled was always equivalent to the number of
cases. Within this framework, deviation of the K function for
DENV seroconversions outside of the probability envelope at a
specific distance was evidence of global clustering (if above the
envelope) or repulsion (if below the envelope) and supports
rejection of the null hypothesis that the patterns are equivalent at a
probability level of 0.01 [37].
Local pattern clustering
Local clustering of serotype-specific DENV seroconversions was
detected using the Kuldorff spatial scan statistic [39,40] with
SaTScan software verson 8.1.1 (http://www.satscan.org). This
method uses a retrospective spatial Bernoulli probability model to
detect significant spatial clustering of cases. Briefly, using the
Bernoulli probability distribution with Monte Carlo simulation
repeated 999 times, the model tests the statistical likelihood of the
distributions of cases in relation to controls for a moving circular
spatial window, determining if a greater than expected number of
cases occurred in an area. We assessed patterns across several
different spatial radii (100, 300, 600 and 900 m) for each serotype-
specific trimester dataset. Spatial scan analyses were only run for a
specific serotype and trimester when more than two seroconver-
sions were observed during that time period. In total, 92 analyses
were conducted (32 for DENV-1, 32 for DENV-2, and 28 for
DENV-3). Identical SaTScan analyses were run on 64 laboratory
confirmed, acute, apparent DENV infections captured by active
surveillance for febrile illness, as described previously (for details
see Morrison et al [25] and Rocha et al [41]).
Results
Study population
A total of 3,110 participants met the inclusion criteria for our
analyses. As described in Morrison et al 2010 [25], the majority of
Spatial Dimensions of Dengue Transmission
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participants (n = 2,393, 76.93%) were under the age of 18. The
number of males (n = 1,305, 41.96%) was less than that of females.
Cases and Controls
Over the course of the study period, we detected a total 607
seroconversions to DENV (68 to DENV-1, 58 to DENV-2 and
481 to DENV-3; Table 1). The total number of controls for each
serotype/trimester is presented in Table 1. The population
included in the analyses varied by serotype for specific years and
trimesters, due to changes in serotype-specific immunity over time.
Seroprevalence
From samples taken between January and October 1999, a total
of 1,999 participants met the inclusion criteria listed above. Of
those, monotypic neutralizing antibodies (NtAbs) against DENV-1
and DENV-2 were detected in 12% (n= 240) and 14.7% (n= 294),
respectively. A total of 1,054 participants (52.7%) had detectable
NtAbs against both DENV-1 and DENV-2 at baseline, whereas
20.6% (n= 411) showed no evidence of prior dengue infection.
These percentages are similar to those reported by Morrison et al
2010 [25], indicating that the population meeting the inclusion
criteria was similar in serostatus to those of the overall cohort.
When analyzed by zone, DENV-1 and DENV-2 seroprevalence
show a distinct geographic structure (Figure 3), similar to that
previously described by Morrison et al 2010 [25]. At the initiation
of the study, the prevalence of DENV-3-specific antibodies was
low (,5%), but rapidly increased city-wide over the course of the
study with distinct differences between city zones.
Invasion of DENV-3 into Iquitos is clearly demonstrated by
changes in temporal and geographic seroprevalence patterns
(Figure 4, Figure 5, Table 2). Transmission was first detected in the
city center (Iquitos [IQ]) during the May–Aug 2001 trimester
(2001.2) and then was detected at rates of less than 5% in all but
one of the eight geographic zones during the Sep–Dec 2001
trimester. Although seroprevalence rates remained low throughout
the city during the first part of 2002, virus was concentrated in the
northern zones of Maynas (MY) and IQ. As indicated by Morrison
et al 2010 [25], other zones lagged behind MY and IQ, with most
failing to reach the levels of seroconversion observed in MY, where
the highest overall DENV transmission rates occurred.
The Spearman r correlation coefficient comparing the DENV-
3 seroprevalence in the first trimester of 2002 with the baseline
seroprevalence of DENV-1/DENV-2 is close to zero (0.24) and is
not statistically significant (p = 0.58). This implies little to no
correlation between the two patterns. The correlation between
DENV-1/DENV-2 seroprevalence and DENV-3 seroprevalence
increased in each subsequent trimester, with r=0.48 (p= 0.24)
and 0.62 (p = 0.12) in the second trimester and third trimesters of
2002, respectively. In the first trimester of 2003, r increased to
0.67 (p= 0.08). It is important to note that these data only follow
the invasion of DENV-3 through its first two years in Iquitos. Due
to a change in the sampling scheme after the 2002–2003
transmission season, we were unable to compare the seropreva-
lence data from the final cohort sample collected in 2005.
Global patterns
To facilitate visual interpretation of the Monte Carlo K-
function results, we plotted the ratio of the difference between the
K functions for cases and controls over the K-function for controls.
We failed to reject the null hypothesis that the pattern of cases was
Figure 2. Distribution of all participants sampled during 4-month interval. Black =DENV-3 susceptible, red =DENV-3 infected,
green=DENV-3 immune.
doi:10.1371/journal.pntd.0001472.g002
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different from that of controls if the cases K function fell between
the high and low control K functions (99% probability envelope).
For DENV-1 and DENV-2, the number of seroconversions within
any given trimester was small and always consistent with the
pattern of controls. When considering all seroconversions within
an epidemiological season, DENV-1 showed evidence of clustering
at ,200 m during the 2001–2002 season. For DENV-2 the
pattern of seroconversions was more widely dispersed than
expected during the 2000–2001 season at distances of ,220 m–
500 m. Overall, however, there was little evidence for spatial
structuring of DENV-1 and DENV-2. In the case of DENV-3, we
observed that during the first trimester when seroconversions
occur (2001.3), the pattern of cases was no different from that of
controls, providing evidence that this new serotype had rapidly
spread within one trimester at low levels to all parts of the city
(Figure 6). In the next trimester (2002.1), however, the pattern was
highly over-dispersed relative to controls across a range of scales
from 200 m to ,700 m. Examination of the pattern of
seroconversions was consistent with there being a focus in the
northern region of the city in the MY zone with additional
seroconversions radiating out from there. During the next
trimester (2002.2) the pattern of cases again indicated over-
dispersion, but at broader scales ,800 m. During the third
trimester (2002.3), DENV-3 seroconversions appeared more
clustered at small scales - ,15 m and ,180 m – possibly
reflecting transmission among neighboring households and within
neighborhoods. During the first trimester of 2003, after the PMoH
intervention, the pattern of cases was no different than that of
controls.
When analyzed by epidemiological season, DENV-3 serocon-
versions were highly clustered relative to expectation up to
,100 m during the initial invasion phase during the 2002 season
(Jul 1 2001–Jun 30 2002). For the 2003 season (Jul 1 2002–Jun 30
2003) cases were equivalent to controls. The fact that at a broader
temporal scale (season) the pattern of seroconversions was
clustered during the 2002 season, while the pattern by trimesters
was over-dispersed, appears to reflect the existence of alternate,
neighborhood-scale (,200–800 m) foci occurring at different
times during the invasion and establishment of the virus.
Local patterns
From the 92 spatial scan analyses run, a total of 23 significant
(p =,0.05) clusters were identified: eight for DENV-1 and 15 for
DENV-3 (Table 3). Of these, 65% (n= 15) had radii greater than
Table 1. Total serotype-specific cases and controls by trimester.
DENV-1
YEAR TRIMESTER CASES CONTROLS POPULATION
1999 MAY–AUG 3 285 288
2000 JAN–APR 10 599 609
2000 SEPT–DEC 6 352 358
2001 JAN–APR 9 296 305
2001 SEPT–DEC 8 289 297
2002 JAN–APR 16 271 287
2002 MAY–AUG 7 392 399
2002 SEPT–DEC 9 344 353
DENV-2
YEAR TRIMESTER CASES CONTROLS POPULATION
1999 MAY–AUG 6 241 247
2000 JAN–APR 18 505 523
2000 MAY–AUG 4 294 298
2000 SEPT–DEC 9 280 289
2001 JAN–APR 3 237 240
2002 JAN–APR 3 236 239
2002 MAY–AUG 6 361 367
2002 SEPT–DEC 9 343 352
DENV-3
YEAR TRIMESTER CASES CONTROLS POPULATION
2001 JAN–APR 4 747 751
2001 MAY–AUG 0 391 391
2001 SEPT–DEC 28 970 998
2002 JAN–APR 69 676 745
2002 MAY–AUG 233 977 1210
2002 SEPT–DEC 130 727 857
2003 JAN–APR 17 520 537
doi:10.1371/journal.pntd.0001472.t001
Spatial Dimensions of Dengue Transmission
www.plosntds.org 6 February 2012 | Volume 6 | Issue 2 | e1472
100 m. No significant clusters were detected for DENV-2 during
any trimester. Similarly, we detected no significant clusters of
febrile cases captured by active surveillance.
Clusters of seroconversions to DENV-1 were spread throughout
the city, with different high-risk zones each trimester (Figure 3). No
visual pattern appeared to link transmission clusters from one
period to the next.
For epidemic DENV-3, however, a more apparent pattern
emerged. As time passed, clusters concentrated in areas following
the distinct pattern of seroprevalence detected for DENV-1 and
DENV-2 during 1999 (Figure 3, Figure 4). Clusters began in the
north of the city, where overall DENV seroprevalence rates were
highest. For example, in the northern region of the city in the
second trimester of 2002 statistically significant clusters are
observed in MY, where seroprevalence rates increased from
12% in the second trimester of 2002 to 27% in the third. In
contrast, in other zones with significant but overall lower DENV
transmission, we were unable to identify statistically significant
clustering.
Discussion
Understanding the underlying spatial dimensions of DENV
transmission in different epidemiological contexts will improve our
understanding of virus transmission dynamics and aid in the
design and deployment of preventative and emergency control
measures. While we did not detect spatial clustering among people
with clinically apparent DENV infections, all infections (i.e.,
apparent and inapparent) exhibited spatially distinct transmission
patterns. Although details of DENV transmission differed between
interepidemic and epidemic periods, we speculate that in Iquitos
human movement is a unifying process in delimiting virus
transmission across different epidemiologic contexts.
During the interepidemic period (1999–2001), DENV-1/
DENV-2 incidence rates were highest in the southern regions of
the city where overall seroprevalence was lowest [25]. Significant
clustering of DENV-2 was not detected throughout this study,
likely due to the fact that only 49 seroconversions were detected
during the study period. However, we did detect significant
Figure 3. Seroprevalence of DEN-1 and DEN-2 in the 8 geographic zones of Iquitos in October 1999. Clusters of DENV-1 are indicated by
colored circles (purple =May–Aug 1999; red = Jan–Apr 2000; pink = Sep–Dec 2001; green= Jan–Apr 2002). No significant clusters of DENV-2 were
identified during the study period.
doi:10.1371/journal.pntd.0001472.g003
Spatial Dimensions of Dengue Transmission
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Figure 4. Seroprevalence of DEN-3 by trimester. Pink circles indicate significant clusters.
doi:10.1371/journal.pntd.0001472.g004
Figure 5. Seroprevalence kernel of DENV-3 by trimester.
doi:10.1371/journal.pntd.0001472.g005
Spatial Dimensions of Dengue Transmission
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clusters of DENV-1 seroconversions in northern regions of the
city, where DENV seroprevalence was highest. Mosquito
populations monitored throughout the study showed high adult
Ae. aegypti indices in the northern zone of Maynas, where
seroprevalence was also highest, indicating an elevated level of
infection risk [25,36].
Our results thus indicate that a positive relationship may exist
between mosquito abundance and the risk of human DENV
infection. At the levels we observed, herd immunity was
insufficient to counteract risk from other factors, such as elevated
mosquito exposure, which could serve as a catalyst for neighbor-
hood-specific variation in DENV transmission. The relationship
between entomological indices and DENV transmission has been
difficult to define [21,22]. Malariologists reported that increased
infective mosquito bites per person per day [entomological
inoculation rate (EIR)] correlates with higher malaria incidence
in humans [42,43,44,45]. A similar relationship has not, however,
been established for DENV and Ae. aegypti, but is worth exploring
in greater detail [46].
We did not identify spatial patterns among 64 people with overt
illness, implying that defining spatial transmission patterns based
solely on clinically apparent DENV infections can be misleading.
Spatial patterns for seroconversions were more easily detected
during the DENV-3 invasion than during the interepidemic
period. After initially spreading rapidly and evenly at low rates
throughout the city, distinct spatial patterns of DENV-3
transmission were detected. For example, MY, the first zone to
experience clusters of DENV-3, also had the highest combined
seroprevalence rates for DENV-1 and DENV-2 prior to the
DENV-3 introduction. DENV-3 transmission started earlier and
was higher overall in MY than in the rest of the city. This
observation was consistent with there being underlying spatial
heterogeneity of DENV transmission in Iquitos, perhaps associ-
ated with some aspect of the mosquito populations, that puts
persons living in certain parts of the city at higher intrinsic risk of
infection than people in other locations.
As DENV-3 invaded the city, its establishment closely followed
the geographic patterns observed for seroprevalence of the DENV
serotypes that preceded it. While the results of the correlation rank
test were not statistically significant at a 0.05 level, the pattern of
DENV-3 seroprevalence appeared to be converging on that of
DENV-1/DENV-2. Had we maintained the same sampling
scheme throughout the remainder of the DENV-3 invasion, we
would anticipate the correlation of the patterns to become
significant. Historic, geographically distinct seroprevalence pat-
terns, therefore, may be useful for prioritizing dengue surveillance
(i.e., infection in humans and/or mosquitoes) and prevention (i.e.,
mosquito control or vaccination). Preemptive intervention could
Table 2. Seroprevalence rates DENV-3 by trimester in the 8 regional zones of Iquitos.
2001 2002 2003
ZONE MAY–AUG SEPT–DEC JAN–APR MAY–AUG SEPT–DEC JAN–APR MAY–AUG
BG 0% 0% 2% 2% 12% 13% 13%
TA 0% 1% 3% 6% 18% 20% 20%
PT 0% 1% 3% 7% 13% 15% 15%
IQ 1% 2% 6% 11% 16% 16% 16%
PU 0% 1% 2% 7% 15% 19% 19%
MC 0% 1% 4% 7% 20% 22% 22%
MY 0% 1% 6% 12% 27% 28% 29%
SA 0% 1% 2% 3% 15% 16% 17%
doi:10.1371/journal.pntd.0001472.t002
Figure 6. Monte Carlo K statistic. The difference between the observed and expected over the expected is plotted against distance, r. The grey
envelope is the 99% probability envelope based on the pattern of controls and the black line is the K function ofor the cases (seroconversions). If the
line strays above the envelope, this indicates clustering. If it strays below, this indicates repulsion or over dispersion.
doi:10.1371/journal.pntd.0001472.g006
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be directed towards areas that are considered particularly
susceptible to elevated risk of virus transmission and from which
virus could spread to other locations. Focusing control on areas of
high transmission may help diminish the impact of a novel virus
invasion. The effect that targeting areas with high levels of
transmission may have on transmission at broader geographic
scales remains to be determined. Targeting areas that theoretically
contribute most to transmission [47,48] is attractive because it
could be a more effective way to use limited resources for disease
prevention than uniform application over large geographic areas
[21,22].
Transmission foci during epidemic and interepidemic periods
had radii that exceeded 100 m in 65% of significant clusters,
indicating that spatial dimensions for DENV transmission
extended beyond the level of individual households and the flight
range Ae. aegypti [3]. The relative role of humans versus mosquitoes
in DENV movement within 100 m has not been resolved. At
greater distances, human movement of virus appears to be an
important factor in defining the spatial dimensions of DENV
transmission regardless of the epidemiologic context; i.e., interep-
idemic and epidemic periods as well as during the invasion and
establishment of a novel virus (Stoddard et al in prep).
Since the completion of our study, DENV-3 caused significant
outbreaks of disease in 2004, 2006–2007, and again in Feb 2008
when the first isolates of DENV-4 in Iquitos were recovered from
participants in a clinic-based fever study [31]. Following its
introduction, DENV-4 became the main circulating virus
throughout the city until late 2010 when an Asian-American
strain of DENV-2 was introduced into Iquitos, causing a large city-
wide outbreak [49,50]. Analyses of the spatial dimensions of these
two serotype introductions would be useful for determining
whether the patterns remain consistent. Because subsequent
epidemiological studies used distinct spatial designs and had
distinct research objectives we are unable to include those data in
this presentation, but we can confirm that MY was one of the first
effected during both the DENV-4 and DENV-2 outbreaks (Scott
and Morrison unpublished).
Our study had three notable limitations. First, since we only
know the time interval during which infection occurred but not its
exact date, we may not have identified all significant virus
transmission clusters. DENV transmission and spread in a
community can happen rapidly. Although drawing blood at six-
month intervals is appropriate for the analysis of seroprevalence
over time, a shorter temporal window between assessments of
serostatus might improve resolution in spatial analyses of DENV
invasion. This limitation might in part account for our inability to
predict clusters in certain areas where seroprevalence rates quickly
increased over time. This could occur because the period between
Table 3. Significant clusters of DEN-1 and DEN-3 from 1999 through April of 2003.
CLUSTERS OF DENV-1
Year Trimester Parameter (meters) Cases Controls Radius (meters) P-value
1999 MAY–AUG 100 3 0 8.7 ,= .001
2000 JAN–APR 600 3 3 330 0.015
2001 SEPT–DEC 300 4 4 200 0.006
2001 SEPT–DEC 600 6 15 530 ,= .001
2001 SEPT–DEC 600 5 17 580 0.015
2001 SEPT–DEC 900 6 23 750 0.008
2002 JAN–APR 600 8 23 600 0.032
2002 JAN–APR 900 10 35 610 0.01
CLUSTERS OF DENV-3
Year Trimester Parameter (meters) Cases Controls Radius (meters) P-value
2001 SEPT–DEC 100 3 0 0 0.015
2001 SEPT–DEC 300 8 29 130 0.004
2002 JAN–APR 100 6 4 33 0.022
2002 JAN–APR 300 18 45 260 0.006
2002 JAN–APR 300 13 30 270 0.032
2002 JAN–APR 600 34 120 600 ,= .001
2002 MAY–AUG 300 20 12 230 0.002
2002 MAY–AUG 300 31 43 250 0.011
2002 SEPT–DEC 100 21 14 98 ,= .001
2002 SEPT–DEC 100 7 0 7.2 0.002
2002 SEPT–DEC 100 9 2 82 0.003
2002 SEPT–DEC 100 5 0 18 0.026
2002 SEPT–DEC 100 5 0 40 0.026
2002 SEPT–DEC 300 30 22 190 ,= .001
2002 SEPT–DEC 300 33 48 150 ,= .001
No significant clusters of DENV-2 were identified during the study period.
doi:10.1371/journal.pntd.0001472.t003
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two blood draws may span two trimesters. For instance if the first
sample was taken November 30 2001 and the second April 28
2002, the middate would occur in the first trimester of 2002,
whereas the actual infection might have occurred in the third
trimester of 2001. Despite these limitations, our analyses still
provide insights across all infections, including those that were
inapparent. Second, because of our sampling scheme, we focused
our spatial analyses of seroprevalence at the zone level. Dividing
the cohort into smaller units (i.e., blocks) would not properly
represent the population. Third, our school-based active surveil-
lance sampling scheme may not have identified all acute DENV
infections and thus contributed to the lack of detectable spatial
patterns among clinically apparent infections. In subsequent
cohort studies, we used a different sampling scheme in an effort
to examine transmission patterns at smaller spatial scales.
Current World Health Organization (WHO) guidelines, which
recommend vector control be administered to households within a
400 m radius of a dengue case, are consistent with the
transmission clusters we detected [51]. Vector control at this scale
in a city such as like Iquitos could, however, require that hundreds
of houses be treated for each case. Consequently, in practice a
radius of 100 m is often adopted. Even though small scale
clustering is clearly important, our local and global analyses
identified a significant proportion of spatial clusters that extended
well beyond 100 m. Our results, therefore, provide an additional
explanation for why vector control within 100 m of a dengue case
has been less successful than desired for larger scale disease
prevention [21,22].
Results from our cluster analyses indicate that if areas of
primary invasion and/or elevated amplification can be treated
based on historical patterns of transmission (i.e., seroprevalence)
either a priori or reactively, it may be feasible to block virus
dispersal. The majority (93%) of clusters we detected had radii
,400 m, indicating that neighborhoods where initial cases are
identified could be intervention targets. A substantial challenge for
reactive control will be the need to quickly apply the intervention
at the correct locations during the early phases of invasion when
most human infections are clinically inapparent and therefore
difficult to detect in disease-based surveillance systems [24].
Alternatively, it may be more productive to focus on character-
izing historical seroprevalence patterns as a means for prioritizing
spatially targeted surveillance and preemptive intervention. The
incidence was previously detected, and from where virus may
disseminate to the other parts of the city.
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